Fed Completed Phase 1 Trials for Levocetirizine (DB06282)

Also known as: FED

IndicationStatusPhase
DBCOND0052071 (Fed)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01567501Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed ConditionTreatment